This indicates that the measurement of the expression levels of LRRC52-AS1, LINC02082, UNC5B-AS1, MPPED2-AS1, LNCNEF, and LOC100129129 could be used for differentiating between benign and malignant tumors in thyroid nodules. This evidence concerns the gene LRRC52 and cancer.